Hollsteen
← Credo

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2018: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2019: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q4 FY2020: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q1 FY2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q2 FY2021: missing – No verified SEC value extracted, although the company reports this metric in other periods.Research and development · Q3 FY2021: $7.0M · 10-Q 0001628280-22-005722 filed Mar 10, 2022Research and development · Q4 FY2021: $8.0M · derived · 10-K 0001628280-22-016593 filed Jun 8, 2022Research and development · Q1 FY2022: $10.0M · 10-Q 0001628280-22-024164 filed Sep 1, 2022Research and development · Q2 FY2022: $12.0M · 10-Q 0001628280-22-031244 filed Dec 1, 2022Research and development · Q3 FY2022: $11.0M · 10-Q 0001628280-22-005722 filed Mar 10, 2022Research and development · Q4 FY2022: $15.0M · derived · 10-K 0001628280-23-023187 filed Jun 23, 2023Research and development · Q1 FY2023: $17.0M · 10-Q 0001628280-22-024164 filed Sep 1, 2022Research and development · Q2 FY2023: $18.0M · 10-Q 0001628280-22-031244 filed Dec 1, 2022Research and development · Q3 FY2023: $21.0M · 10-Q 0001628280-23-006114 filed Mar 2, 2023Research and development · Q4 FY2023: $21.0M · derived · 10-K 0001628280-24-029629 filed Jun 24, 2024Research and development · Q1 FY2024: $23.0M · 10-Q 0001628280-23-030893 filed Aug 29, 2023Research and development · Q2 FY2024: $22.0M · 10-Q 0001628280-23-040371 filed Nov 30, 2023Research and development · Q3 FY2024: $24.0M · 10-Q 0001628280-24-007677 filed Feb 28, 2024Research and development · Q4 FY2024: $27.0M · derived · 10-K 0001628280-25-033813 filed Jul 2, 2025Research and development · Q1 FY2025: $30.0M · 10-Q 0001628280-24-039562 filed Sep 5, 2024Research and development · Q2 FY2025: $32.0M · 10-Q 0001628280-24-049786 filed Dec 3, 2024Research and development · Q3 FY2025: $36.0M · 10-Q 0001628280-25-011738 filed Mar 10, 2025Research and development · Q4 FY2025: $48.0M · derived · 10-K 0001628280-26-043303 filed Jun 15, 2026Research and development · Q1 FY2026: $52.0M · 10-Q 0001807794-25-000021 filed Sep 4, 2025Research and development · Q2 FY2026: $58.0M · 10-Q 0001628280-25-054549 filed Dec 2, 2025Research and development · Q3 FY2026: $78.0M · 10-Q 0001628280-26-014017 filed Mar 3, 2026Research and development · Q4 FY2026: $91.0M · derived · 10-K 0001628280-26-043303 filed Jun 15, 2026Research and development · Q1 FY2027: $115M · 10-Q 0001628280-26-060111 filed Sep 2, 2026missing90.5a114.57.0Q1 FY2016Q1 FY2027
$MResearch and development · Q2 FY2025: $32.0M · 10-Q 0001628280-24-049786 filed Dec 3, 2024Research and development · Q3 FY2025: $36.0M · 10-Q 0001628280-25-011738 filed Mar 10, 2025Research and development · Q4 FY2025: $48.0M · derived · 10-K 0001628280-26-043303 filed Jun 15, 2026Research and development · Q1 FY2026: $52.0M · 10-Q 0001807794-25-000021 filed Sep 4, 2025Research and development · Q2 FY2026: $58.0M · 10-Q 0001628280-25-054549 filed Dec 2, 2025Research and development · Q3 FY2026: $78.0M · 10-Q 0001628280-26-014017 filed Mar 3, 2026Research and development · Q4 FY2026: $91.0M · derived · 10-K 0001628280-26-043303 filed Jun 15, 2026Research and development · Q1 FY2027: $115M · 10-Q 0001628280-26-060111 filed Sep 2, 202690.5a114.531.7Q2 FY2025Q1 FY2027
Q4 FY2026
90.5a$M
derived
All values (23)
PeriodValue ($M)Status
Q1 FY2027114.5reported
Q4 FY202690.5derived
Q3 FY202678.5reported
Q2 FY202657.9reported
Q1 FY202652.4reported
Q4 FY202548.5derived
Q3 FY202536.3reported
Q2 FY202531.7reported
Q1 FY202530.4reported
Q4 FY202426.9derived
Q3 FY202424.2reported
Q2 FY202421.7reported
Q1 FY202422.6reported
Q4 FY202321.4derived
Q3 FY202320.5reported
Q2 FY202318.2reported
Q1 FY202316.7reported
Q4 FY202215.5derived
Q3 FY202211.0reported
Q2 FY202211.8reported
Q1 FY20229.7reported
Q4 FY20218.2derived
Q3 FY20217.0reported

22 periods without value hidden · Show gaps with reason · CSV with all sources · Technical ID: rnd

More metrics for Credo

Income statement

Per share

Balance sheet

Cash flow

Revenue by segment/product/region

Sources & calculation
Value
$91.0M (derived)
Period
Q4 FY2026, ended May 2, 2026 · quarterly value (3 months, not cumulative)
Calculation
Q4 = fiscal year − 9 months cumulative = 279M − 189M = $91.0M (FY value from 10-K 0001628280-26-043303; 9-month value from the Q3-10-Q)
Source
10-K, filed Jun 15, 2026 · 0001628280-26-043303
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$91.0MJun 15, 202610-K 0001628280-26-043303derived · confidence 1. · current